Pharmacy
Mohamad Takwa, CEO of Epigenica, an epigenetic-profiling company based in Sweden talks about the technology and its opportunities for healthcare, including the creation of epigenetic drugs.
Naomi Fried, PharmStars' founder and CEO, discusses the company's spring 2023 cohort, and its call for applications to digital health groups across the world who focus on women's health and health equity for underserved populations.
What are the roles for technology, clinicians and pharmacies in responding to the social determinants of health? Iris Frye and Nicholas Christiano Jr., co-chairs of Health Equity Policy Task Force under the HIMSS Public Policy Committee, discuss.
HIMSS22
Bob Katter, president of First Databank, explains how the FDB Vela electronic prescribing network can improve contracting and access for clinicians and pharmacies.
HIMSS21
PharmStars, through its PharmaU program, is mentoring digital health startups and coaching pharma executives to prepare both parties for successful partnerships, says founder and CEO Naomi Fried.
HIMSS21
Rebecca Sulfridge, clinical pharmacy specialist, emergency medicine, at Covenant HealthCare, shares how using AI to check medication histories helped limit face-to-face contact during COVID-19.
Dr. Brian Covino, chief medical officer at Cohere Health, talks about reducing payer and provider friction and the CMS' proposed rule on prior authorizations.
This week's top stories include Dr. David Feinberg leaving Google Health to serve as Cerner's CEO as Google dismantles its health division, and the FDA giving full approval to the Pfizer/BioNTech COVID-19 vaccine.
This week's top stories include Scripps being hit with four class-action lawsuits, AWS creating a new accelerator, and five Blue Cross Blue Shield plans launching a for-profit company focused on lowering drug prices.
This week's top stories include Hims & Hers expanding beyond the U.S. market with the acquisition of British personalized health company Honest Health and the AHA asking Express Scripts to rescind its 340B claims reporting policy.